SAN FRANCISCO (Thomson Financial) - Omrix Biopharmaceuticals Inc. late
Thursday named Larry Ellberger board chairman.
The New York-based biopharmaceutical company also named Pamela McNamara to
its board. McNamara was formerly a director of Omrix, the firm said.
Omrix shares closed the regular session up 9 cents at $15.27.
Brigid Gaffikin
bg/kh
COPYRIGHT
Copyright Thomson Financial News Limited 2007. All rights reserved.
The copying, republication or redistribution of Thomson Financial News Content,
including by framing or similar means, is expressly prohibited without the prior
written consent of Thomson Financial News.
|